We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
DF
151
Donoghue Forlines
Massachusetts
$2.92M +$2.09M +15,214 +285%
HSBC Holdings
152
HSBC Holdings
United Kingdom
$2.86M +$871K +6,323 +46%
BAMF
153
BI Asset Management Fondsmaeglerselskab
Denmark
$2.77M +$2.69M +19,554 New
OAM
154
Oxford Asset Management
United Kingdom
$2.69M +$1.4M +10,133 +115%
BIM
155
Bogle Investment Management
Massachusetts
$2.67M +$2.59M +18,813 New
Treasurer of the State of North Carolina
156
Treasurer of the State of North Carolina
North Carolina
$2.64M -$1.86M -13,475 -42%
BG
157
Bahl & Gaynor
Ohio
$2.64M -$39.1K -284 -2%
LPL Financial
158
LPL Financial
California
$2.59M -$21.1K -153 -0.8%
AB
159
Amalgamated Bank
New York
$2.56M +$219K +1,590 +10%
TC
160
TAP Consulting
Missouri
$2.54M +$2.47M +17,912 New
KeyBank National Association
161
KeyBank National Association
Ohio
$2.53M +$490K +3,562 +25%
Voloridge Investment Management
162
Voloridge Investment Management
Florida
$2.52M -$1.12M -8,153 -31%
LSERS
163
Louisiana State Employees Retirement System
Louisiana
$2.51M -$151K -1,100 -6%
CT
164
Cambridge Trust
Massachusetts
$2.49M +$7.71K +56 +0.3%
AG
165
Advisor Group
Arizona
$2.49M -$69.4K -504 -3%
Caisse de Depot et Placement du Quebec (CDPQ)
166
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$2.43M +$2.36M +17,158 New
GIP
167
Granite Investment Partners
California
$2.34M +$63.3K +460 +3%
AAM
168
Advisors Asset Management
Colorado
$2.28M +$239K +1,739 +12%
LCM
169
Laurion Capital Management
New York
$2.24M +$2.18M +15,800 New
UBPAM
170
Union Bancaire Privee Asset Management
New York
$2.21M -$110K -800 -5%
Natixis Advisors
171
Natixis Advisors
Massachusetts
$2.16M -$730K -5,301 -26%
GHCM
172
Glen Harbor Capital Management
California
$2.13M – – –
MS
173
Maven Securities
Jersey
$2.05M +$2M +14,553 New
PNC Financial Services Group
174
PNC Financial Services Group
Pennsylvania
$2.03M -$911K -6,616 -32%
SEC
175
Seven Eight Capital
New York
$2.01M +$1.96M +14,200 New
5 6
7
8 9

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.